Reply To: SARS cov2 and Covid 19


Latest News Forums Discussion Forum SARS cov2 and Covid 19 Reply To: SARS cov2 and Covid 19

#64263
node
Guest

Dredd : “You say the vaccine is “poorly tested” but the MHRA (which is responsible for scrutinising the studies and approving it) politely disagrees. Whom to believe? Hmmm.”

Me!

There are no (zero) completed clinical trials for the BNT vaccine. Only Phase 1 of a 3 phase trial has been partially completed (its results were announced before the minimum term for assessing serious adverse events had elapsed). In MHRA’s Public Assessment Report, they state: “At the time of writing, the main clinical study is still on-going….”

MHRA conclude the vaccine is safe and effective based on data from 195 test subjects from the partially completed phase 1 as supplied by the R&D of the vaccine manufacturer (Pfizer and BioNTech) with no independent scrutiny. “Pfizer was responsible for the trial design; for the collection, analysis, and interpretation of the data; and for the writing of the report.” Only 39 vulnerable aged subjects received the vaccine, and about half reported some adverse reactions.

I repeat: “the vaccine is poorly tested”

P.S. Recent tender request : The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs)….it is not possible to retrofit the MHRA’s legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine.